本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Forte BioSciences Inc

15.49
+2.0515.25%
盘后15.600.1100+0.71%19:58 EDT
成交量:6.52万
成交额:93.80万
市值:1.93亿
市盈率:-1.88
高:15.49
开:13.41
低:13.41
收:13.44
52周最高:28.68
52周最低:4.11
股本:1,243.29万
流通股本:926.19万
量比:0.61
换手率:0.70%
股息:- -
股息率:- -
每股收益(TTM):-8.2404
每股收益(LYR):-12.1671
净资产收益率:-73.46%
总资产收益率:-40.79%
市净率:1.95
市盈率(LYR):-1.27

数据加载中...

2024/11/15

重要事件披露

Form 8-K - Current report
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/09/20

重要事件披露

Form 8-K - Current report
2024/08/30

重要事件披露

Form 8-K - Current report
2024/08/22

重要事件披露

Form 8-K - Current report
2024/08/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/14

重要事件披露

Form 8-K - Current report
2024/06/17

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/06/14

重要事件披露

Form 8-K - Current report
2024/05/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/13

重要事件披露

Form 8-K - Current report
2024/04/29

[修订]年度报告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2024/04/12

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/18

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/18

重要事件披露

Form 8-K - Current report
2024/02/16

重要事件披露

Form 8-K/A - Current report: [Amend]
2024/02/15

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/15

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/15

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]